Goldman Sachs’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $20K | Sell |
|
|||||
|
2021
Q4 | $40K | Sell |
|
|||||
|
2021
Q3 | $238K | Buy |
|
|||||
|
2021
Q2 | $234K | Buy |
|
|||||
|
2021
Q1 | $149K | Buy |
|
|||||
|
2020
Q4 | $87K | Sell |
|
|||||
|
2020
Q3 | $271K | Buy |
|
|||||
|
2020
Q2 | $29K | Sell |
|
|||||
|
2020
Q1 | $59K | Sell |
|
|||||
|
2019
Q4 | $148K | Buy |
|
|||||
|
2019
Q3 | $117K | Buy |
|
|||||
|
2019
Q2 | $58K | Sell |
|
|||||
|
2019
Q1 | $96K | Buy |
|
|||||
|
2018
Q4 | $118K | Buy |
|
|||||
|
2018
Q3 | $133K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $743K | Buy |
|
|||||
|
2017
Q4 | $61K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $27K | Sell |
|
|||||
|
2016
Q2 | $35K | Buy |
|